The latest report by IMARC Group, titled "Biological Safety Cabinet Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on the global biological safety cabinet market trends. The global biological safety cabinet market size reached US$ 222.6 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 343.6 Million by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2023-2028.
A biological safety cabinet (BSC), or microbiological safety cabinet, is an enclosed, ventilated laboratory workspace designed to protect the surrounding environment and personnel from pathogenic microorganisms. It comprises high-efficiency particulate absorbing (HEPA) filtration systems that decontaminate the air flowing out of the cabinet. Depending on the level of product protection, biosafety cabinets are classified into I, II and III classes. Amongst these, class I and II cabinets are primarily used for the safe manipulation of moderate- and high-risk microorganisms. On the other hand, class III BSCs are ideal for working with hazardous agents with biosafety levels 3 and 4. These workspaces can be customized according to the user preference to obtain optimum control over quality and minimize contamination risks.
Request For Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/biological-safety-cabinet-market/requestsample
Biological Safety Cabinet Market Trends and Drivers:
The BSC market growth is majorly being driven by the increasing risks of communicable diseases and the sudden outbreak of coronavirus disease (COVID-19) across the globe. Additionally, significant expansion in the biotechnology and life sciences sectors is further propelling the market growth. Besides this, the rising expenditure in the improvement of healthcare infrastructure and numerous investments in research and development (R&D) by pharmaceutical and biopharmaceutical companies are positively influencing the market growth. Moreover, diagnostic labs and pharmaceutical manufacturers are increasingly utilizing BSCs to maintain the microbiological quality of drugs, which is acting as a growth-inducing factor for the market. Furthermore, the introduction of advanced product variants with improved construction, airflow pattern, velocities and exhaust systems is creating a positive outlook for the market.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Type:
Class I
Class II
Class II Type A
Class II Type B
Class III
Breakup by End User:
Pharmaceutical and Biopharmaceutical Companies
Diagnostic and Testing Laboratories
Academic and Research Institutions
Market Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape with Key Player:
Air Science
Berner International
BIOBASE
Esco Micro Pte Ltd.
EUROCLONE SPA (AddLife Development AB)
Germfree Laboratories
Kewaunee Scientific Corporation
Labconco
NuAire (Polypipe)
The Baker Company, Inc.
Thermo Fisher Scientific Inc.
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=reportid=2670flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal